April 23, 2018 USADA announced today that it has confirmed two compounding pharmacies in Brazil produced and sold contaminated supplements that led to the positive tests of three athletes subject to the UFC® Anti-Doping Policy.

Compounding Pharmacies Supply Tainted Supplements Behind ...

https://ufc.usada.org › Announcement

9 hours ago - In addition to medications, both compounding pharmacies investigated by USADA also produced and sold nutritional supplements, and marketed their products as a safe alternative to mass produced medications and supplements.

Iowa Board of Pharmacy Actions

PUBLIC DOCUMENTS: Press Control and click on licensee’s name to follow link to view document.

Daniel Baldi, DO, entered into a Settlement Agreement and Final Order with the Board. The Board ordered his CSA registration be permanently restricted from prescribing, administering, and dispensing controlled substances for the treatment of chronic pain. In addition, his CSA registration will be restricted for the duration of his probation with the Iowa Board of Medicine.

Wells Pharmacy, entered into a Combined Amended Statement of Charges, Settlement Agreement, and Final Order with the Board. The Board issued a citation and warning for violating the laws and rules governing the practice of pharmacy and ordered a civil penalty in the amount of $12,000.00. In addition, the order requires the pharmacy to remain PCAB-accredited at all times and to verify all prescribers for Iowa patients are properly licensed.

Walgreens Pharmacy 05942, entered into a Combined Statement of Charges, Settlement Agreement, and Final Order with the Board. The Board issued a citation and warning for violating the laws and rules governing pharmacies. The Board furthered ordered a civil penalty in the amount of $1,500.00.

Michael Lyons, Pharmacist, entered into a Combined Statement of Charges, Settlement Agreement, and Final Order with the Board. The Board issued a citation and warning for violating the laws and rules governing the practice of pharmacy. The Board furthered ordered a civil penalty in the amount of $500.00.

Tobin Jacks, MD, entered into a Combined Order to Show Cause, Settlement Agreement, and Final Order with the Board. The Board ordered his CSA registration be restricted during the duration of his Memorandum of Agreement with the DEA.

Mark Pithan, MD, entered into a Combined Order to Show Cause, Settlement Agreement, and Final Order with the Board. The Board ordered his CSA registration be restricted during the duration of his Memorandum of Agreement with the DEA.

McKesson Corporation, Wholesaler 5037, was granted a Controlled Substance Act registration with restrictions mirroring restrictions on their DEA registration.

McKesson Corporation, Wholesaler 5772, was granted a Controlled Substance Act registration with restrictions mirroring restrictions on their DEA registration.

Janice Kirsch, MD, entered into a Combined Order to Show Cause, Settlement Agreement, and Final Order with the Board. The Board ordered her CSA registration be restricted during the duration of her Memorandum of Agreement with the DEA.

Iowa Board of Pharmacy: Distinguished Pharmacy. Following a hearing, the Board ordered the nonresident pharmacy license be revoked.

Distinguished Pharmacy. Following a hearing, the Board ordered the nonresident pharmacy license be revoked.

Iowa Board of Pharmacy Announces PMP Change in Reporting Frequency Effective May 16, 2018

• 04/23/2018 – PMP - Change in reporting frequency effective May 16, 2018

California Board of Pharmacy and Inspectors Continue to Lead the Way in Investigations and Enforcement Actions

Alisal LTC Pharmacy, PHY 50018, Administrative Case AC 6286
Salinas, CA
Accusation Filed 2/14/2018; Case pending.
View the accusation

Anatomy Pharmacy, PHY 50713, Administrative Case AC 5987
Los Angeles, CA
Accusation Filed 2/28/2018; Case pending.
View the accusation

Anatomy Pharmacy, LSC 99715, Administrative Case AC 5987
Los Angeles, CA
Accusation Filed 2/28/2018; Case pending.
View the accusation

Animal Solutions Pharmacy Inc., PHY 51088, Administrative Case AC 6068
Santa Rosa, CA
First Amended Accusation Filed 2/15/2018; Case pending.
View the accusation

Animal Solutions Pharmacy Inc., PHY 54438, Administrative Case AC 6068
Santa Rosa, CA
First Amended Accusation Filed 2/15/2018; Case pending.
View the accusation

Arlington Prescription Pharmacy, PHY 47307, Administrative Case AC 6214
Riverside, CA
Accusation Filed 2/2/2018; Case pending.
View the accusation

BrandMD, PHY 50543, Administrative Case AC 6127
Chatsworth, CA
Accusation Filed 2/28/2018; Case pending.
View the accusation

Daniels Pharmacy, PHY 36740, Administrative Case AC 6213
San Francisco, CA
Accusation Filed 2/1/2018; Case pending.
View the accusation

Kaiser Foundation Hospital Inpatient/Outpatient Pharmacy 31A 315, HSP 6602, Administrative Case AC 6212
San Francisco, CA
Accusation Filed 2/1/2018; Case pending.
View the accusation

Los Banos Drug Co., PHY 48861, Administrative Case AC 6081
Los Banos, CA
Accusation Filed 2/1/2018; Case pending.
View the accusation

New Age Pharmaceuticals Inc., PHY 48626, Administrative Case AC 5252
Los Angeles, CA
Second Amended Accusation Filed 2/23/2018; Case pending.
View the accusation

Pharmacy 9, PHY 40841, Administrative Case AC 6178
Santa Ana, CA
Accusation Filed 2/1/2018; Case pending.
View the accusation

The Medicine Shoppe, PHY 51646, Administrative Case AC 6231
Riverside, CA
First Amended Accusation Filed 2/12/2018; Case pending.
View the accusation

***

Cal-Mex Pharmacy, PHY 50374, Administrative Case AC 5985
Calexico, CA
Through a disciplinary action of the Board, the license is revoked and the right to practice or operate has ended.
Decision effective 4/12/2018.
View the decision

Pharmacy Resources Incorporated., NSC 99697, Statement of Issues Case SI 6091
Denver, CO
Statement of Issues withdrawn.
Decision effective 4/10/2018.
View the decision

West Aid Pharmacy and Medical Supply, PHY 48785, Administrative Case AC 5941
Los Angeles, CA
Through a disciplinary action of the Board, the license is voluntarily surrendered.
Decision effective 4/12/2018.
View the decision